Quince Therapeutics Competitors and Similar CompaniesClear all
Quince Therapeutics's competitors and similar companies include Alector.
 Quince Therapeutics Quince Therapeutics (formerly known as Cortexyme) is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | |
Founding Date | Founding Date 2012 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ | Locations San Francisco, US HQ |
Employees | Employees 2321% increase | Employees 2382% decrease |
Valuation ($) | Valuation ($) 51.1 m | Valuation ($) 495.3 m |
Financial | ||
Net income | Net income ($84m) (FY, 2025) | Net income ($142.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 194.5m |
For sources of this data, please see the company profile
View Company Profiles
Alector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View company